Wenbin Jiang, President and CEO at Cytek Biosciences, Inc. (CTKB), sold 40,000 shares at $10.13 ($405K) on 2023-03-07, disclosed to the SEC on 2023-03-07.
Open-market sale of $405k CTKB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.13 | 20,000 | $203K | 50.0% |
| 2 | $10.13 | 20,000 | $203K | 50.0% |
| Total | $10.13 avg | 40,000 | $405K | 100% |
| Filing → |
| CTKB | SELL | 2023-09-08 | $137K | — | Filing → |
| CTKB | SELL | 2023-08-08 | $362K | — | Filing → |
| CTKB | SELL | 2023-07-07 | $170K | — | Filing → |